β-Blocker therapy in heart failure: Pathophysiology and clinical results

Current Problems in Cardiology

Volumn 24, Issue 7, 1999, Pages 421-460

  Carson, Peter E ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARBAZOLE DERIVATIVE; CARVEDILOL; IMIDAZOLE DERIVATIVE; METOPROLOL; PROPANOLAMINE DERIVATIVE; PROPRANOLOL; VASODILATOR AGENT; XAMOTEROL; ACEBUTOLOL; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LABETALOL; LISINOPRIL; NEBIVOLOL; TIMOLOL;

AGED; CASE REPORT; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; EXERCISE; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; TIME; BETA ADRENERGIC RECEPTOR BLOCKING; DRUG EFFICACY; DRUG SELECTIVITY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; KINESIOTHERAPY; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; AGED; BISOPROLOL; CARBAZOLES; CLINICAL TRIALS; EXERCISE; HEART FAILURE, CONGESTIVE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; IMIDAZOLES; MALE; METOPROLOL; MIDDLE AGED; PROPANOLAMINES; PROPRANOLOL; QUALITY OF LIFE; STROKE VOLUME; TIME FACTORS; VASODILATOR AGENTS; XAMOTEROL;

EID: 0032985547     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-2806(99)90007-5     Document Type: Article

References (29)

1. Burden of heart failure. 1997 Heart and stroke statistical update American Heart Association; 1997.
2. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;37:1022-6.
3. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1979;I:1264-6.
4. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J 1980;44:117-33.
5. Swedberg K, Hjalmarson A, Waagstein F, et al. Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. Br Heart J 1980;44:134-42.
6. Waagstein F, Caidahl K, Wallentin I, Bergh CH, Hjalmarson A. Long-term β-blockade in dilated cardiomyopathy: effects of short- and long term metoprolol treatment followed by withdrawal and re-administration of metoprolol. Circulation 1989;80:551-63.
7. Soufer R, Wohlgelernter D, Vita NA, et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985;55:1032-6.
8. Davis JO. An extra-adrenal sodium-retaining factor in congestive heart failure. J Card Failure 1995;1:179-82.
9. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
10. Waagstein F, Hjalmarson A, Wasir HS. Apex cardiogram and systolic time intervals in acute myocardial infarction and effect of practolol. Br Heart J 1974;36:1109-21.
11. Bristow MR, Ginsburg R, Umans V, et al. Beta 1 and beta 2-adrenergic subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor downregulation in heart failure. Cir Res 1989;59:297-309.
12. Cohn JN, Levine B, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
13. Singh N, Dhalla K, Seneviratne C, Singal PK. Oxidative stress and heart failure. Mol Cell Biochem 1995;147:77-81.
14. Zau D. Circulating and tissue renin-angiotensin system. Arch Intern Med 1993;153:937-42.
15. Simpson P. Norepinephrine stimulated hypertrophy of cultured rat myocardial cells is an α-1 adrenergic response. J Clin Invest 1983;72:732-8.
16. Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet 1990;2:294-5.
17. Mann DL, Kent RL, Parsons B, Cooper G IV. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992;85:790-804.
18. Molina-Viamonte V, Anyukhovsky EP, Rosen MR. An alpha-1-adrenergic receptor subtype is responsible for delayed afterdepolarizations and triggered activity during simulated ischemia and reperfusion of isolated canine Purkinje fibers. Circulation 1991;84:1732-40.
19. Francis GS, Cohn NJ, Johnson G, et al for the V-HeFT VA Cooperative Studies Group. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Circulation 1993;87(Suppl VI):VI-40-VI-48.
20. Gilbert EM, Olsen SL, Renlund DG, Bristow MR. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. Am J Cardiol 1993;71:23C-29C.
21. 1-receptor mRNA abundance in the failing human heart. Circulation 1993;92:2737-45.
22. Yatani A, Brown AM. Rapid β-adrenergic modulation of cardiac calcium channel currents by a fast G protein pathway. Science 1989;245:71-4.
23. Bristow MR, Port JD, Gilbert EM. The role of receptor regulation in the treatment of heart failure. Cardiovasc Drug Ther 1989;3:971-8.
24. Yoshikawa T, Port JD, Asano K, et al. Cardiac adrenergic receptor effects of carvedilol. Eur Heart J 1996;17(Suppl B):8-16.
25. Gilbert EM, Sandoval A, Larrabee P, Renlund DG, O'Connell JB, Bristow MR. Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart. Circulation 1993;88:472-80.
26. Volpe M, Tritto C, Deluca N, et al. Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation 1993;88:1620-7.
27. Lechat P. Prevention of heart failure progression: current approaches. Eur Heart J 1998;19(Suppl B):B12-B18.
28. Just H. Pathophysiological targets for beta-blocker therapy congestive heart failure. Eur Heart J 1996;17(Suppl B):2-7.
29. Imperato-McGinley J, Gautier T, Ehlers K, Zullo T, Goldstein DS, Vaughan ED. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a phaeocnromocytoma. N Engl J Med 1987;316:793-7.